✦ LIBER ✦

A cost-effectiveness analysis of a community pharmacist-initiated disease state management service for type 2 diabetes mellitus

✍ Scribed by Dr. Susan J. Taylor; Tsveta Milanova; Fleur Hourihan; Ines Krass; Clare Coleman; Carol L. Armour

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A computer simulation model for cost–eff

✍ Tony Hsiu-Hsi Chen; Ming-Fang Yen; Tao-Hsin Tung 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 73 KB

PDB57 Cost-Effectiveness of Adding a Pha

✍ J. Yu; B. Shah; E.J. Ip; J. Chan 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Cost Effectiveness Analysis of a Hyperte

✍ David Ly; Fu Z. Alex; Hebert Christopher 📂 Article 📅 2009 🏛 Le Jacq Communications, Inc. 🌐 English ⚖ 240 KB

PDG6: COST-EFFECTIVENESS OF PIOGLITAZONE

✍ F Henriksson; A Brandt; L Thomander; A Kielhorn; R Jansen; N Maniadakis 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 52 KB

PDB45 COST-EFFECTIVENESS ANALYSIS OF SAX

✍ de Ramirez; A Arellano; M Brosa; J Franch; D Mauricio; C Alvarez; M Sanchez-Zamo 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

Integrating the community pharmacist int

✍ J. WERMEILLE; M. BENNIE; I. BROWN 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB